Dasotraline Binge Eating Disorder Study

Status:
Completed

Trial end date:
2016-10-01

Target enrollment:

Participant gender:

Evaluate the efficacy of flexibly-dosed dasotraline compared with placebo in adults with moderate to severe Binge Eating Disorder (BED)

Phase 2/Phase 3

Sunovion